WallStreetZenWallStreetZen

NASDAQ: SHLT
Shl Telemedicine Ltd Stock Forecast, Predictions & Price Target

Analyst price target for SHLT

Based on 1 analyst offering 12 month price targets for Shl Telemedicine Ltd.
Min Forecast
$11.00+104.46%
Avg Forecast
$11.00+104.46%
Max Forecast
$11.00+104.46%

Should I buy or sell SHLT stock?

Based on 1 analyst offering ratings for Shl Telemedicine Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SHLT stock forecasts and price targets.

SHLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-14

1 of 1

Forecast return on equity

Is SHLT forecast to generate an efficient return?

Forecast return on assets

Is SHLT forecast to generate an efficient return on assets?

SHLT revenue forecast

What is SHLT's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$62.0M+8.63%
Avg 2 year Forecast
$75.0M+31.41%
SHLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SHLT revenue growth forecast

How is SHLT forecast to perform vs Health Information Services companies and vs the US market?
Company
8.63%
Industry
13.32%
Market
13.38%
SHLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SHLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SHLT vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
SHLT$5.38$11.00+104.46%Strong Buy
FORA$2.77$5.00+80.51%Strong Buy
TBRG$8.09$17.00+110.14%Buy
SY$1.24N/AN/A
BEAT$2.04$8.00+292.16%Buy

Shl Telemedicine Stock Forecast FAQ

Is Shl Telemedicine Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SHLT) stock is to Strong Buy SHLT stock.

Out of 1 analyst, 1 (100%) are recommending SHLT as a Strong Buy, 0 (0%) are recommending SHLT as a Buy, 0 (0%) are recommending SHLT as a Hold, 0 (0%) are recommending SHLT as a Sell, and 0 (0%) are recommending SHLT as a Strong Sell.

If you're new to stock investing, here's how to buy Shl Telemedicine stock.

What is SHLT's revenue growth forecast for 2024-2025?

(NASDAQ: SHLT) Shl Telemedicine's forecast annual revenue growth rate of 8.63% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.38%.

Shl Telemedicine's revenue in 2024 is $57,075,000.On average, 1 Wall Street analysts forecast SHLT's revenue for 2024 to be $1,016,350,748, with the lowest SHLT revenue forecast at $1,016,350,748, and the highest SHLT revenue forecast at $1,016,350,748.

In 2025, SHLT is forecast to generate $1,229,456,550 in revenue, with the lowest revenue forecast at $1,229,456,550 and the highest revenue forecast at $1,229,456,550.

What is SHLT's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: SHLT) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 6.26%.

What is SHLT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SHLT price target, the average SHLT price target is $11.00, with the highest SHLT stock price forecast at $11.00 and the lowest SHLT stock price forecast at $11.00.

The Wall Street analyst predicted that Shl Telemedicine's share price could reach $11.00 by Mar 14, 2025. The average Shl Telemedicine stock price prediction forecasts a potential upside of 104.46% from the current SHLT share price of $5.38.

What is SHLT's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: SHLT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.